Grifols, ES0171996087

Grifols stock pre-market at EUR 10.09 ahead of the Xetra open

Published on 10/20/2026 at 08:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Grifols develops and distributes therapeutic products, mainly from human plasma. At Lang & Schwarz, the stock trades pre-market at EUR 10.09 on October 20, 2026.

Business model and trading date

Grifols develops and distributes therapeutic products, with a primary focus on medicines derived from human plasma.
The pre-market quote is dated October 20, 2026.
Grifols stock trades pre-market at EUR 10.09 at 8:31 a.m. CEST at Lang & Schwarz on October 20, 2026.

Aquarellbild von Barcelona mit Hafen, Bergen und mediterranem Licht — Aquarellmalerei zeigt die Küstenstadt Barcelona als Sitz von Grifols S.A. ES0171996087 in weichen, warmen Farbtönen, Illustration mit AI erstellt.

Grifols stock is at EUR 10.09 in pre-market trading at Lang & Schwarz at 8:31 a.m. CEST on October 20, 2026.

The group’s operations

Grifols develops, manufactures and distributes therapeutic products, with a primary focus on medicines derived from human plasma, and also supplies diagnostic products and healthcare solutions.

Pre-market indication

The quoted bid was EUR 10.07 and the ask EUR 10.11. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Grifols stock.

What Grifols does

The company serves healthcare markets through plasma-derived medicines, diagnostic products, hospital-related products and biological materials for life-science applications.

Market context: Market report IBEX 35.

More news and analysis on Grifols stock